Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
about
Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linkingEukaryotic stress granules are cleared by autophagy and Cdc48/VCP functionMutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALSUpdate in inclusion body myositisTargeting protein homeostasis in sporadic inclusion body myositis.The Myoblast C2C12 Transfected with Mutant Valosin-Containing Protein Exhibits Delayed Stress Granule Resolution on Oxidative Stress.Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP diseaseSporadic inclusion body myositis: the genetic contributions to the pathogenesis.TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.Theories of the pathogenesis of inclusion body myositis.Aquaporin-4 expression in distal myopathy with rimmed vacuoles.Ongoing developments in sporadic inclusion body myositisSporadic inclusion body myositis: new insights and potential therapy.Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.Proteasome dysfunction induces muscle growth defects and protein aggregation.Molecular markers for granulovacuolar degeneration are present in rimmed vacuoles.Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis.Myofibrillar disruption and RNA-binding protein aggregation in a mouse model of limb-girdle muscular dystrophy 1DMuscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model.Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositisNeuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.De novo prion aggregates trigger autophagy in skeletal muscle.Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly.Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkersNovel therapeutic approaches for inclusion body myositis.Review: An update on inflammatory and autoimmune myopathies.State of the art and the dark side of amyotrophic lateral sclerosis.Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.Common pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders.Understanding ALS: new therapeutic approaches.Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis.
P2860
Q24300438-5E83AC81-5CB7-43AC-AFBB-B025E0CD4DCBQ24629019-0D60659B-1EC7-4C43-859C-71ACEBD11A1FQ24629495-129B2768-6C94-4462-84EF-944993E21C7DQ26829906-52F1BD3E-0905-40B4-BBA1-497D595B12B8Q27324564-7E086A4E-396C-4082-98F4-26E2F9CB86F9Q30008982-ABCD3005-EEBC-4F7D-8003-3D7E55D94D29Q30492839-85651B82-0632-45AE-91F7-F06A5D004903Q30573122-6101EA71-7368-4C53-960D-68DBADA01318Q33589965-3C041079-67C3-4F3F-BBA2-83A024698BD5Q33806912-E296AB09-5B6B-45D2-B019-75E9E39373A1Q33932237-BEA09D84-6A17-4C25-B159-D6B46E530824Q34090910-F9FDA5FF-B29C-414C-84C0-D591E13FC0B3Q34249539-2A450146-5E9C-48B1-B567-54ED164E850EQ34519540-E7647AB8-84E5-4ECD-AC6A-695B05C03482Q34591787-068CFD3A-9A9F-4604-BE3A-A7C94614C8BEQ34675925-6AC8EE4E-5FCC-4FC8-846B-A04AD9F0396BQ34698515-4F462ACD-0BA9-48D3-AA00-DF5D48843D6BQ35060401-8C6618D4-66CD-4107-932F-F1E61DE7F48BQ35607479-3CD7D299-96CB-4C19-A104-068515D40ABAQ36251979-2C02E0EC-942C-4877-8DE0-4786553863FDQ36486041-840ED56B-180C-4B3D-BA7A-B345FC260327Q36575286-DF569B4E-120E-4E28-907E-D1D728224DF4Q37062875-51690B70-C7A4-4E17-821C-55124E719FB6Q37485423-1F80F28D-E7BA-448C-B8E2-C9F14DBD7ECCQ37547167-87235061-30A4-480D-BF35-E6F28239001AQ37599978-C7D2C4D4-25C2-469E-8B43-B74F316C6473Q37706412-F87E765F-A9ED-43D7-8511-8D06118AC317Q37733168-6C256A63-35E0-4D8A-AFB6-013E5FA1741BQ37776127-54E624A3-8FD5-437D-B03D-049FF4292205Q37786521-F81A094C-78B1-4123-B1C1-5F1E48BB452FQ37820692-62672B1E-44A3-464A-B788-094149E57C44Q37871837-7E30651C-CC7B-49EB-B616-2ED641D21136Q37886653-6CD569C5-4BC0-4115-B952-1998BF5A72F0Q37903412-0BD38BB8-BB6E-4570-957E-296C2BBC3BD8Q37904288-6A626B05-9A81-4A29-B42C-FE5B370DBAA1Q37956169-07ADAF8D-666C-409D-A44F-AD07ADCA1B47Q38065343-EBAF5DDC-C1A6-4F5D-8B9E-E4E07548174FQ38314711-D2CA0C5E-C5D3-4FCA-A857-BE35C3E507D3Q38589301-C2173B05-A306-44A7-BAF8-9F2ECAB8BD2DQ38701291-9DDFB114-1F92-432B-AA50-95D3FF38EC88
P2860
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@ast
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@en
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@nl
type
label
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@ast
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@en
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@nl
prefLabel
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@ast
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@en
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@nl
P2093
P2860
P356
P1433
P1476
Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis
@en
P2093
Anthony A Amato
Jack L Pinkus
Mohammad Salajegheh
Remedios Nazareno
Robert H Baloh
Steven A Greenberg
P2860
P356
10.1002/MUS.21386
P407
P577
2009-07-01T00:00:00Z